96 results
Page 3 of 5
8-K
EX-1.1
onh4a00
27 Apr 23
MAIA Biotechnology, Inc. Announces Pricing of Public Offering
5:25pm
424B4
dbujd4u6h2
25 Apr 23
Prospectus supplement with pricing info
7:45pm
FWP
dvwh7pfi6cl4knjw5
20 Apr 23
Free writing prospectus
9:38am
8-K
t2p7jszyezx09ztm4w
20 Apr 23
MAIA Biotechnology Reports Preliminary Survival Data in Part A of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
8:43am
8-K
EX-99.1
ktp4piwlm3jeqnacdlmw
20 Apr 23
MAIA Biotechnology Reports Preliminary Survival Data in Part A of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
8:43am
FWP
s9eacxq0kth4lu6y5g
18 Apr 23
Free writing prospectus
3:08pm
FWP
t72o8h6l 22
11 Apr 23
Free writing prospectus
8:30am
8-K
37ce0c748ncxe
11 Apr 23
MAIA Biotechnology Reports Positive Topline Data from Part A Safety Lead-In of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
8:15am
8-K
EX-99.1
oylvj55 sg6i
11 Apr 23
MAIA Biotechnology Reports Positive Topline Data from Part A Safety Lead-In of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
8:15am
FWP
krp74z52jvg3w
6 Apr 23
Free writing prospectus
6:24pm
DRS
2371pnm
23 Dec 22
Draft registration statement
12:00am
8-K
EX-99.1
zrp5uryjfic04fd
9 Nov 22
MAIA Biotechnology Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:30pm
8-K
EX-10.3
2jtih90e77sd0
21 Sep 22
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
bc42zi7azdmiee2v17z
21 Sep 22
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.2
2ym0lf y1
21 Sep 22
Departure of Directors or Certain Officers
4:15pm